BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27670094)

  • 1. Gonadal hormone modulation of ∆
    Craft RM; Haas AE; Wiley JL; Yu Z; Clowers BH
    Pharmacol Biochem Behav; 2017 Jan; 152():36-43. PubMed ID: 27670094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
    Wakley AA; Wiley JL; Craft RM
    Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
    Craft RM; Leitl MD
    Eur J Pharmacol; 2008 Jan; 578(1):37-42. PubMed ID: 17905227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of gonadal hormones on cannabinoid dependence.
    Marusich JA; Craft RM; Lefever TW; Wiley JL
    Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
    Tseng AH; Harding JW; Craft RM
    Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat.
    Wakley AA; McBride AA; Vaughn LK; Craft RM
    Pharmacol Biochem Behav; 2014 Sep; 124():269-77. PubMed ID: 24951841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol-Δ
    Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
    Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats.
    Stoffel EC; Ulibarri CM; Folk JE; Rice KC; Craft RM
    J Pain; 2005 Apr; 6(4):261-74. PubMed ID: 15820914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats.
    Stoffel EC; Ulibarri CM; Craft RM
    Pain; 2003 Jun; 103(3):285-302. PubMed ID: 12791435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.
    Craft RM; Britch SC; Buzitis NW; Clowers BH
    Exp Clin Psychopharmacol; 2019 Aug; 27(4):338-347. PubMed ID: 31120286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol modulation of antinociceptive tolerance to Δ
    Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
    Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat.
    Wakley AA; Wiley JL; Craft RM
    Drug Alcohol Depend; 2014 Oct; 143():22-8. PubMed ID: 25131716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.
    Tseng AH; Craft RM
    Psychopharmacology (Berl); 2004 Feb; 172(1):25-30. PubMed ID: 14991224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex, THC, and hormones: Effects on density and sensitivity of CB
    Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
    Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gonadal steroids in the corticotropin-releasing hormone and proopiomelanocortin gene expression response to Delta(9)-tetrahydrocannabinol in the hypothalamus of the rat.
    Corchero J; Manzanares J; Fuentes JA
    Neuroendocrinology; 2001 Sep; 74(3):185-92. PubMed ID: 11528220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
    Craft RM; Kandasamy R; Davis SM
    Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific modulation of spinal nociception by alpha2-adrenoceptors: differential regulation by estrogen and testosterone.
    Thompson AD; Angelotti T; Nag S; Mokha SS
    Neuroscience; 2008 Jun; 153(4):1268-77. PubMed ID: 18434028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociception and sedation following intracerebroventricular administration of Δ⁹-tetrahydrocannabinol in female vs. male rats.
    Wakley AA; Craft RM
    Behav Brain Res; 2011 Jan; 216(1):200-6. PubMed ID: 20692296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.